Vaxart Plans to Push COVID-19 Vaccine Candidate into the Clinic
Excerpt From the Article:
Bay Area-based Vaxart, Inc. has obtained positive pre-clinical results for its COVID-19 vaccine candidates, with several of the vaccine candidates generating immune responses in all tested animals after a single dose. Now, the company plans to push one or more into the clinic.
Sean Tucker, Vaxart’s chief scientific officer, said the early preclinical results for the COVID-19 vaccines are in line with the company’s universal flu vaccine candidate, which is now in Phase II testing.
Click the button below to read the entire article:
Request Your Demo Today!
From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?